134 related articles for article (PubMed ID: 2665352)
21. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
Kar HK; Sharma AK; Misra RS; Zaheer SA; Mukherjee A; Mukherjee R; Beena KR; Kaur H; Nair SK; Talwar GP
Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525
[TBL] [Abstract][Full Text] [Related]
22. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
Gupte MD; Vallishayee RS; Anantharaman DS; Britto RL; Nagaraju B
Indian J Lepr; 1996; 68(4):315-24. PubMed ID: 9001899
[TBL] [Abstract][Full Text] [Related]
23. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
[TBL] [Abstract][Full Text] [Related]
24. Adoptive transfer of tolerance induced by ICRC bacilli against Mycobacterium leprae in mice.
Jeevan A; Bapat CV; Deo MG
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):437-45. PubMed ID: 3528346
[TBL] [Abstract][Full Text] [Related]
25. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
De Britto RL; Ramanathan VD; Gupte MD
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
[TBL] [Abstract][Full Text] [Related]
26. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
28. Anti-leprosy vaccines--field trials and future prospects.
Deo MG
Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
[TBL] [Abstract][Full Text] [Related]
29. Leprosy vaccine--a puzzle.
Job CK
Lepr India; 1983 Jan; 55(1):1-7. PubMed ID: 6348409
[No Abstract] [Full Text] [Related]
30. ICRC vaccine-induced changes in M. leprae-specific cell-mediated immunity in langur (Presbytis entellus) monkeys.
Chirmule NB; Deo MG; Sirodkar MV; Deshmukh R; Chanderkar NG
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):57-62. PubMed ID: 3519805
[TBL] [Abstract][Full Text] [Related]
31. India carries out large-scale tests of anti-leprosy vaccine.
Jayaraman KS
Nature; 1987 Aug 20-26; 328(6132):660. PubMed ID: 3302728
[No Abstract] [Full Text] [Related]
32. ELISA & lepromin skin tests in household contacts of leprosy patients.
Dhandayuthapani S; Anandan D; Bhatia VN
Indian J Med Res; 1990 Nov; 91():431-6. PubMed ID: 2091988
[TBL] [Abstract][Full Text] [Related]
33. Vaccine trials against leprosy.
Gupte MD
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):587-9. PubMed ID: 10347583
[No Abstract] [Full Text] [Related]
34. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae.
Shetty VP; Mistry NF; Wakade AV; Ghate SD; Capadia GD; Pai VV
Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880
[TBL] [Abstract][Full Text] [Related]
35. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
36. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
Gormus BJ; Meyers WM
Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
[TBL] [Abstract][Full Text] [Related]
37. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
[TBL] [Abstract][Full Text] [Related]
38. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
39. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
[TBL] [Abstract][Full Text] [Related]
40. BCG vaccination in leprosy.
Price JE
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
